patrick durez

UCLouvain

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Bernard Combe

Professor of Rheumatology, Head of the department of Rheumatology, Head of the medical and surgical bones and joint departments

University of Montpellier

FRANCE

View details

Roy Fleischmann

Clinical Professor of Medicine

University of Texas Southwestern Medical Center

UNITED STATES

View details

Raquel Largo

SPAIN

View details

Hubert Marotte

University hospital of Saint Etienne

FRANCE

View details

Aurélie Najm

University of Glasgow

UNITED KINGDOM

View details

Myles J Lewis

Professor

Queen Mary University of London

UNITED KINGDOM

View details

Andrew Filer

Professor of Translational Rheumatology

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

patrick durez

Research Interests

Explore related searches

Contact this professor

Articles (10)

Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study

Sexual dysfunction in male patients treated with methorexate for arthritis: Analysis of the IIEF5 questionnaire and hormonal status

Should we stop methotrexate or not for vaccination?

Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort

Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

An update on the adalimumab biosimilar landscape following approval of the first high-concentration biosimilar

EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology

Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study

Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort

Collaborators (7)

Bernard Combe

Roy Fleischmann

Raquel Largo

Hubert Marotte

Aurélie Najm

Myles J Lewis

Andrew Filer

Make your next move.